Molecular Mechanisms of Neonatal Brain Injury
Author(s) -
Claire Thornton,
Catherine I. Rousset,
Anton Kichev,
Yasuka Miyakuni,
Regina Vontell,
Ana A. Baburamani,
Bobbi Fleiss,
Pierre Gressèns,
Henrik Hagberg
Publication year - 2012
Publication title -
neurology research international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.365
H-Index - 31
eISSN - 2090-1852
pISSN - 2090-1860
DOI - 10.1155/2012/506320
Subject(s) - medicine , neuroprotection , excitotoxicity , neonatal encephalopathy , encephalopathy , hypothermia , hypoxic ischemic encephalopathy , ischemia , pathophysiology , traumatic brain injury , brain damage , bioinformatics , anesthesia , intensive care medicine , glutamate receptor , pathology , psychiatry , receptor , biology
Fetal/neonatal brain injury is an important cause of neurological disability. Hypoxia-ischemia and excitotoxicity are considered important insults, and, in spite of their acute nature, brain injury develops over a protracted time period during the primary, secondary, and tertiary phases. The concept that most of the injury develops with a delay after the insult makes it possible to provide effective neuroprotective treatment after the insult. Indeed, hypothermia applied within 6 hours after birth in neonatal encephalopathy reduces neurological disability in clinical trials. In order to develop the next generation of treatment, we need to know more about the pathophysiological mechanism during the secondary and tertiary phases of injury. We review some of the critical molecular events related to mitochondrial dysfunction and apoptosis during the secondary phase and report some recent evidence that intervention may be feasible also days-weeks after the insult.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom